Zobrazeno 1 - 10
of 84
pro vyhledávání: '"карведилол"'
Autor:
S. Y. Martsevich, N. P. Kutishenko, E. V. Shilova, A. D. Deev, S. A. Shalnova, R. G. Oganov, I. A. Veliganina, E. G. Volkova, Yu. E. Voskanjan, L. I. Gapon, P Ya. Dovgalevskij, V. Ya. Ermolina, E. M. Idrisova, N. N. Ilov, A. R. Kiselev, S. Yu. Levashov, V. A. Nevzorova, G. I. Nechaeva, T. N. Panova, I. I. Reznik, V. V. Skibickij, L. A. Sokolova, V. P. Terentev, N. V. Hailo, A. V. Shabalin, T. V. Shnjukova, V. V. Yakusevich
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 5, Iss 2, Pp 33-38 (2016)
Aim. To compare two therapies based on carvedilol or metoprolol in hypertensive patients with overweight and obesity.Material and methods. 320 patients with arterial hypertension (1-2 degree) were involved in the study. 160 patients received carvedil
Externí odkaz:
https://doaj.org/article/56bcbd6ba29447fbacb6f5a7a14fa368
Autor:
A. R. Kiselev, V. I. Gridnev, A. S. Karavaev, O. M. Posnenkova, V. A. Shvarts, V. I. Ponomarenko, M. D. Prokhorov, B. P. Bezruchko
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 5, Iss 3, Pp 55-61 (2016)
Aim. To study effects of carvedilol and metoprolol on vegetative regulation of heart and microcirculatory vessels in patients with arterial hypertension (HT) of 1-2 degrees and high body mass/obesity.Material and methods. Patients with HT of 1-2 degr
Externí odkaz:
https://doaj.org/article/37751306292e4ec58cccfdd077ec2d5d
Autor:
S. Y. Martsevich, N. P. Kutishenko, E. V. Shilova, A. D. Deev, S. A. Shalnova, R. G. Oganov, I. A. Velishanina, E. G. Volkova, Yu. E. Voskanjan, L. I. Gapon, P. Ya. Dovgalevskij, V. Ya. Ermolina, E. M. Idrisova, N. N. Ilov, A. R. Kiseleva, S Yu. Levashov, V. A. Nevsorova, G. I. Nechaeva, T. N. Panova, I. I. Reznik, V. V. Skibickij, L. A. Sokolova, V. P. Terentev, N. V. Hailo, A. V. Shabalin, T. V. Shnyukova, V. V. Yakusevich, E. N. Akulina, V. A. Budanova, T. S. Bondarenko, V. P. Voronina, I. N. Gozhaja, I. I. Igricenco, A. V. Drogan, N. A. Dmitrieva, F. M. Dyshekova, A. I. Zaiceva, A. N. Ikovnikova, G. A. Ilicheva, I. S. Irhina, L. A. Kovaleva, O. N. Kutkina, E. A. Kudrjashev, A. Z. Leonidova, E. N. Loginova, M. P. Marganjan, O. V. Nastradin, A. N. Nikitina, I. N. Nikolskaja, I. E. Pashinceva, A. S. Petrochenko, O. M. Pasnenkova, E. S. Potapova, A. A. Serazhim, M. N. Sergeev, V. V. Sidorenko, V. A. Simonov, D. V. Sirotenko, I. N. Spanderashvili, A. N. Strunina, E. S. Timoschenko, S. N. Tolpygina, M. R. Redkina
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 5, Iss 1, Pp 23-27 (2016)
Aim. To evaluate antihypertensive and metabolic effects of the therapy based on carvedilol (C) in comparison with metoprolol (M) in hypertensive patients with overweight or obesity.Material and methods. 320 patients were involved in multicenter, rand
Externí odkaz:
https://doaj.org/article/71cf5cefa79142f79d9280e0339a945d
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 5, Iss 3, Pp 19-24 (2016)
Aim. To study efficacy and safety of beta-blocker with vasodilating properties carvedilol (Acridilole, Akrihin, Russia) as a part of the combined therapy of patients with arterial hypertension (HT) and diabetes mellitus 2 type (DM2) and/or obesity.Ma
Externí odkaz:
https://doaj.org/article/3b7e7009cd374e35a11712909eda3f5c
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 5, Iss 4, Pp 51-57 (2016)
Results of large randomized clinical trails on beta-blockers therapy of myocardial infarction (MI) with ST segment elevation (COMMIT/CCS-2, CAPRICORN) are analyzed. Last changes in guidelines regarding beta-blockers prescription to patients with MI a
Externí odkaz:
https://doaj.org/article/c7a8e45924cd4a7ea91fcd40f9301b57
Autor:
O. V. Fedorishina, A. A. Dzizinsky, K. V. Protasov, V. A. Protasova, T. I. Kucherova, E. G. Zakharova, D. D. Baskhaeva, T. S. Sukhoroslova, O. V. Perkova
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 5, Iss 5, Pp 41-45 (2016)
Aim. To evaluate a short-term efficacy and safety of nebivolol and carvedilol in hypertensive patients of different ages in acute pharmacological test (APT).Material and methods. 119 patients with arterial hypertension (HT) 2-3 degrees aged 33-89 y.o
Externí odkaz:
https://doaj.org/article/e678fc47e83e44958948a5616fb5c929
Autor:
S. Y. Martsevich, S. N. Tolpygina
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 8, Iss 4, Pp 488-499 (2015)
Aim. To compare antihypertensive and metabolic effects of long-term treatment with carvedilol or bisoprolol in patients with arterial hypertension (HT) of 1-2 degree and overweight/obesity. Material and methods. A total of 105 patients were enrolled
Externí odkaz:
https://doaj.org/article/165c4289f6bd4a45a491f822517ae006
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 3, Iss 4, Pp 19-24 (2015)
Aim. To assess the effect of β-adrenoblockers (BAB) on myocardial remodeling, immuno-inflammatory reactions and endothelial dysfunction in patients with ischemic heart disease and chronic heart failure (CHF).Material and methods. 84 patients with is
Externí odkaz:
https://doaj.org/article/1b46992809b847f99435853943bc5220
Autor:
S. Y. Martsevich, S. N. Tolpigina
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 8, Iss 5, Pp 626-635 (2015)
Aim. To compare antihypertensive and metabolic effects as well as influence on erectile function (EF) of long-term treatment with carvedilol or bisoprolol in patients with arterial hypertension (HT) of 1-2 degree and overweight/obesity. Material and
Externí odkaz:
https://doaj.org/article/a1595d1314544361a6cc4866fa410bfb
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 1, Iss 3, Pp 11-16 (2015)
Aim. To compare effects of long term therapy with сarvedilol and bisoprolol on heart and renal functions, heart rate variability (HRV) and quality of life in elderly patients with chronic heart failure (CHF).Material and methods. We examined 40 pati
Externí odkaz:
https://doaj.org/article/70ed0ed4b2974ab9a8627f6e5987b9ed